Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dobutamine: ten years later.

T C Majerus1, J F Dasta, J L Bauman

  • 1Eli Lilly and Company, Indianapolis, Indiana.

Pharmacotherapy
|January 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

<i>Ex Vivo</i> Urinary Bactericidal Activity and Urinary Pharmacodynamics of Fosfomycin after Two Repeated Dosing Regimens of Oral Fosfomycin Tromethamine in Healthy Adult Subjects.

Antimicrobial agents and chemotherapy·2019
Same author

In vitro activity of oritavancin alone or in combination against vancomycin-susceptible and -resistant enterococci.

The Journal of antimicrobial chemotherapy·2019
Same author

Synapse selection based on differences in synapse turnover.

International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience·2014
Same author

Chromium intake and urinary chromium excretion of trauma patients.

Biological trace element research·2013
Same author

Apoptosis and congestive heart failure.

Trends in cardiovascular medicine·2011
Same author

Pharmacology of the angiotensin II receptor antagonist, eprosartan.

Expert opinion on investigational drugs·2005
Same journal

The Effect of Multiple Doses of Itraconazole on the Pharmacokinetics of a Single Oral Dose of Zongertinib in Healthy Male Volunteers.

Pharmacotherapy·2026
Same journal

Menopausal Hormone Therapy: A Narrative Review of Contemporary Evidence.

Pharmacotherapy·2026
Same journal

Getting It Right the Second Time: How Can we Optimize First-Generation Cephalosporin Dosing for Skin and Soft Tissue Infections in the 21st Century?

Pharmacotherapy·2026
Same journal

Buprenorphine Initiation During Extracorporeal Membrane Oxygenation Decreases Sedative and Opioid Exposure: A Retrospective Matched Case-Control Study.

Pharmacotherapy·2026
Same journal

Voriconazole Dosing and Therapeutic Drug Monitoring in Patients Before and After Liver Transplantation.

Pharmacotherapy·2026
Same journal

Quantifying the Serum Magnesium Response and Predictors of Response Following Intravenous Magnesium Replacement in Critically Ill Patients.

Pharmacotherapy·2026
See all related articles

Dobutamine, a heart failure medication, improves cardiac output and reduces pressure in the blood vessels. While effective for short-term use, higher doses may cause arrhythmias.

Area of Science:

  • Pharmacology
  • Cardiology

Background:

  • Dobutamine is a widely used positive inotrope for short-term heart failure management.
  • It is available as a mixture of two isomers with distinct adrenergic receptor effects.

Purpose of the Study:

  • To summarize the effects and applications of dobutamine in managing heart failure and related conditions.
  • To highlight the importance of understanding underlying pathophysiology in selecting catecholamine therapy.

Main Methods:

  • Review of existing evidence on dobutamine's pharmacological actions and clinical efficacy.
  • Analysis of dobutamine's use in various cardiac conditions and shock states.

Main Results:

  • Dobutamine (2-15 µg/kg/min) increases cardiac output, reduces vascular resistance and filling pressures, and improves renal blood flow.

Related Experiment Videos

  • Higher doses can lead to increased heart rate and arrhythmias.
  • Dobutamine's effects may persist after plasma elimination, with potential for ambulatory use.

    • Conclusions:

    • Dobutamine is effective in improving hemodynamic parameters and symptoms in acute heart failure, post-cardiac surgery, myocardial infarction, and shock.
    • Therapeutic decisions involving dobutamine should consider the patient's underlying condition and potential for combination therapy with other agents like dopamine.